E7 - Protein E7 - Human papillomavirus type 18 - E7 gene & proteinE7 - Protein E7 - Human papillomavirus type 18 - E7 gene & protein

sp,P06788,VE7_HPV18 Protein E7 OS=Human papillomavirus type 18 OX=333761 GN=E7 PE=1 SV=2 ... Human papillomavirus type 18. ,p>This subsection of the ,a href="http://www.uniprot.org/help/names_and_taxonomy_section">Names ... Cited for: INTERACTION WITH HUMAN TMEM173, FUNCTION, MUTAGENESIS OF 25-LEU--GLU-29. ... Cited for: INTERACTION WITH HUMAN TMEM173, FUNCTION, MUTAGENESIS OF 25-LEU--GLU-29. ...
more infohttps://www.uniprot.org/uniprot/P06788

E2 - Regulatory protein E2 - Human papillomavirus type 18 - E2 gene & proteinE2 - Regulatory protein E2 - Human papillomavirus type 18 - E2 gene & protein

Human papillomavirus type 18Imported. Automatic assertion inferred from database entriesi ... tr,Q80B71,Q80B71_HPV18 Regulatory protein E2 OS=Human papillomavirus type 18 OX=333761 GN=E2 PE=3 SV=1 ... IPR000427 Papillomavirus_E2_C. IPR001866 Papillomavirus_E2_N. IPR033668 Reg_prot_E2. IPR036050 Regulatory_protein_E2_N. ... IPR000427 Papillomavirus_E2_C. IPR001866 Papillomavirus_E2_N. IPR033668 Reg_prot_E2. IPR036050 Regulatory_protein_E2_N. ...
more infohttps://www.uniprot.org/uniprot/Q80B71

High Whole-Genome Sequence Diversity of Human Papillomavirus Type 18 Isolates.High Whole-Genome Sequence Diversity of Human Papillomavirus Type 18 Isolates.

The most commonly found human papillomavirus (HPV) types in cervical cancer are HPV16 and HPV18. Genome variants of these types ... Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection. RATIONALE: Vaccines made from human papillomavirus ... Human Papillomavirus Type 18 Isolates.". The most commonly found human papillomavirus (HPV) types in cervical cancer are HPV16 ... Human Papillomavirus 18. A type of human papillomavirus especially associated with malignant tumors of the genital and ...
more infohttps://www.bioportfolio.com/resources/pmarticle/1960374/High-Whole-Genome-Sequence-Diversity-of-Human-Papillomavirus-Type-18-Isolates.html

Association of human papillomavirus types 16 and 18 E6 proteins with p53 | ScienceAssociation of human papillomavirus types 16 and 18 E6 proteins with p53 | Science

Human papillomavirus type 16 (HPV-16) is a DNA tumor virus that is associated with human anogenital cancers and encodes two ... The ability of the E6 proteins from different human papillomaviruses to form complexes with p53 was assayed and found to ... Association of human papillomavirus types 16 and 18 E6 proteins with p53 ... Association of human papillomavirus types 16 and 18 E6 proteins with p53 ...
more infohttps://science.sciencemag.org/content/248/4951/76

Clinical Trial of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine - Full Text View - ClinicalTrials.govClinical Trial of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine - Full Text View - ClinicalTrials.gov

Clinical Trial of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine. This study has been completed. ... Safety of an Escherichia coli-expressed bivalent human papillomavirus (types 16 and 18) L1 virus-like particle vaccine: an open ... An Open-Label, Single-dose, Non-Randomized, Safety and Tolerability Study of Recombinant Human Papillomavirus Virus 16/18 ... Experimental: HPV 16/18 Participants in this arm would intramuscularly receive 90mcg of HPV 16/18 bivalent vaccine at 0, 1, 6 ...
more infohttps://clinicaltrials.gov/show/NCT01263327

Human Papillomavirus 18 Genetic Variation and Cervical Cancer Risk Worldwide. - NextBio articleHuman Papillomavirus 18 Genetic Variation and Cervical Cancer Risk Worldwide. - NextBio article

Human Papillomavirus 18 Genetic Variation and Cervical Cancer Risk Worldwide. Alyce A Chen, Tarik Gheit, Silvia Franceschi, ... Humans Molecular Typing Oncogene Proteins, Viral Open Reading Frames Papillomavirus Infections Phylogeny Phylogeography Risk ... Human Papillomavirus 18 Genetic Variation and Cervical Cancer Risk Worldwide. Journal of virology. 2015 Oct;89(20):10680-7 ... Human papillomavirus 18 (HPV18) is the second most carcinogenic HPV type, after HPV16, and it accounts for approximately 12% of ...
more infohttp://www.nextbio.com/b/search/article.nb?id=26269181

Modulation of the Cell Division Cycle by Human Papillomavirus Type 18 E4 | Journal of VirologyModulation of the Cell Division Cycle by Human Papillomavirus Type 18 E4 | Journal of Virology

The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol. 65:473-478. ... Disruption of the G1/S transition in human papillomavirus type 16 E7-expressing human cells is associated with altered ... Expression of human papillomavirus type 1 E4 gene products in warts, p. 115-122. In B. M. Steinberg, J. L. Brandsma, and L. B. ... The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937. ...
more infohttps://jvi.asm.org/content/76/21/10914

Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytesTwo AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes

... Thierry, F. Institut ... The activity and epithelial tropism of the human papillomavirus type 18 P105 early promoter, which directs the synthesis of the ... These results implicate JunB as an important factor in human papillomavirus type 18 transcription in keratinocytes and strongly ... Mutation of both elements completely abolished P105 promoter activity in human keratinocytes. We show that either AP1 site can ...
more infohttp://liu.diva-portal.org/smash/record.jsf?pid=diva2:656010

Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent(Type 16/18 (Vaccine - Full Text View -...Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent(Type 16/18 (Vaccine - Full Text View -...

Human Papillomavirus 16. Human Papillomavirus 18. vaccine. Cervical Intraepithelial Neoplasia. cervical Cancer. Vaginal ... Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent(Type 16/18 (Vaccine. This study is ongoing, but ... Drug Information available for: Human Papillomaviruses Genetic and Rare Diseases Information Center resources: Cervical ... Approximately 6000 study subjects will be enrolled and randomly stratified into 2 groups and receive human papillomavirus (HPV ...
more infohttps://clinicaltrials.gov/ct2/show/NCT01735006?recr=Open&cond=%22Uterine+Cervical+Diseases%22&rank=17

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by...Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by...

Human papillomavirus 16/18 AS04-adjuvanted vaccine prevented cervical intraepithelial neoplasia in young women. [Ann Intern Med ... Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by ... The human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine was immunogenic, generally well tolerated, and effective against ... The HPV-16/18 AS04-adjuvanted vaccine showed high efficacy against CIN2+ associated with HPV-16/18 and non-vaccine oncogenic ...
more infohttps://www.ncbi.nlm.nih.gov/pubmed/19586656

HUMAN PAPILLOMAVIRUS HPV HIGH RISK AND HPV 16 18 GENOTYPINGHUMAN PAPILLOMAVIRUS HPV HIGH RISK AND HPV 16 18 GENOTYPING

Home , Patient Care , Specialties and Services , Pathology , HUMAN PAPILLOMAVIRUS HPV HIGH RISK AND HPV 16 18 GENOTYPING ... HUMAN PAPILLOMAVIRUS (HPV) HIGH RISK AND HPV 16/18 GENOTYPING Synonym(s): ... as well as to assess for the presence or absence of HPV types 16 and 18. This information, together with the physicians ...
more infohttps://www.sgh.com.sg/patient-care/specialties-services/human-papillomavirus-hpv-high-risk-and-hpv-16-18-genotyping

Human Papillomavirus Types 16 and 18 Vaccine (Recombinant, AS04 Adjuvanted, Adsorbed) [Cervarix™] | Springer for Research &...Human Papillomavirus Types 16 and 18 Vaccine (Recombinant, AS04 Adjuvanted, Adsorbed) [Cervarix™] | Springer for Research &...

Schiffman M. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing. Cancer 2007; 111(3): ... Human papillomavirus and cervical cancer. Lancet 2007 Sep 8; 370(9590): 890-907PubMedCrossRefGoogle Scholar ... Human papillomavirus types 16 and 18 vaccine (recombinant, AS04 adjuvanted, adsorbed). Drugs 2008; 68(3): 359-72PubMedCrossRef ... Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003 Jan 13; 88(1): 63-73PubMed ...
more infohttps://rd.springer.com/article/10.2165/00063030-200822030-00006

The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive...The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive...

The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive ... The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive ... The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive ... The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive ...
more infohttp://cebp.aacrjournals.org/content/5/5/329

Epidemiologic Factors Associated with Seropositivity to Human Papillomavirus Type 16 and 18 Virus-Like Particles and Risk of...Epidemiologic Factors Associated with Seropositivity to Human Papillomavirus Type 16 and 18 Virus-Like Particles and Risk of...

Epidemiologic Factors Associated with Seropositivity to Human Papillomavirus Type 16 and 18 Virus-Like Particles and Risk of ... Epidemiologic Factors Associated with Seropositivity to Human Papillomavirus Type 16 and 18 Virus-Like Particles and Risk of ... Epidemiologic Factors Associated with Seropositivity to Human Papillomavirus Type 16 and 18 Virus-Like Particles and Risk of ... Epidemiologic Factors Associated with Seropositivity to Human Papillomavirus Type 16 and 18 Virus-Like Particles and Risk of ...
more infohttps://cebp.aacrjournals.org/content/19/2/511.figures-only

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine...Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine...

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine ... administration schedule, female adolescents, immunogenicity, human papillomavirus (HPV) vaccines, safety, 2D, 2-dose, 3D, 3- ... human papillomavirus, HPV-16, 18(2D), 2-dose schedule of the HPV-16, 18 vaccine, HPV-6, 11, 16, 2-dose schedule of the HPV-6, ... Human Vaccines & Immunotherapeutics On the subject. Immunology in the medical areaMedical Biotechnology (with a focus on Cell ...
more infohttp://www.diva-portal.org/smash/record.jsf?pid=diva2:847496

Intratype variants of the E2 protein from human papillomavirus type 18 induce different gene expression profiles associated...Intratype variants of the E2 protein from human papillomavirus type 18 induce different gene expression profiles associated...

Persistent infections with high-risk human papillomaviruses (HR-HPVs) are linked to development of cervical cancer due to a ... Schnabel C, Steger G, Schmidt H-M (2002) The hinge region of the human papillomavirus type 8 E2 protein activates the human ... Sunthamala N, Pang CL, Thierry F et al (2014) Genome-wide analysis of high risk human papillomavirus E2 proteins in human ... Wu E-Q, Tang Y-Y (2014) Research progress in roles of high-risk human papillomavirus E2 protein. Chin J Virol 30:201-207Google ...
more infohttps://link.springer.com/article/10.1007%2Fs00705-018-04124-6

Identification of the Human Papillomavirus Type 18 E6* and E6 Proteins in Nuclear Protein Fractions from Human Cervical...Identification of the Human Papillomavirus Type 18 E6* and E6 Proteins in Nuclear Protein Fractions from Human Cervical...

Identification of the Human Papillomavirus Type 18 E6* and E6 Proteins in Nuclear Protein Fractions from Human Cervical ... Identification of the Human Papillomavirus Type 18 E6* and E6 Proteins in Nuclear Protein Fractions from Human Cervical ... Identification of the Human Papillomavirus Type 18 E6* and E6 Proteins in Nuclear Protein Fractions from Human Cervical ... Identification of the Human Papillomavirus Type 18 E6* and E6 Proteins in Nuclear Protein Fractions from Human Cervical ...
more infohttp://cancerres.aacrjournals.org/content/48/11/2969

Methylation of the L1 gene and integration of human papillomavirus 16 and 18 in cervical carcinoma 
and premalignant lesionsMethylation of the L1 gene and integration of human papillomavirus 16 and 18 in cervical carcinoma and premalignant lesions

High-risk human papillomavirus (HPV) is the primary cause of cervical carcinoma (CC). Viral integration into the host ... Methylation of the L1 gene and integration of human papillomavirus 16 and 18 in cervical carcinoma and premalignant lesions. * ... Methylation of the L1 gene and integration of human papillomavirus 16 and 18 in cervical carcinoma and premalignant lesions. ... Methylation of the L1 gene and integration of human papillomavirus 16 and 18 in cervical carcinoma and premalignant lesions. ...
more infohttps://www.spandidos-publications.com/ol/15/2/2278/abstract

Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer...Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer...

Cervical cancerHuman papillomavirusVaccineCervarixHungaryCost-effectiveness. Background. Since the introduction of human ... Ault KA: Long-term efficacy of human papillomavirus vaccination. Gynecol Oncol. 2007, 107 (2 Suppl 1): 27-30.View ArticleGoogle ... Munoz N, Bosch FX, Castellsagué X, Díaz M, de Sanjose S, Hammouda D, Shah KV, Meijer CJ: Against which human papillomavirus ... The aim of this study was to assess the cost-effectiveness of adding vaccination with the human papillomavirus 16/18 vaccine to ...
more infohttps://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-12-924

Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and...Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and...

Genital papillomaviruses differ from other human and animal papillomaviruses as they possess a longer E1 open reading frame ( ... and may represent an evolutionary intermediate among oncogenic papillomaviruses. Viral gene products known to be involved in ... Phylogenetically, HPV 18 is located between the benign genital viruses, HPV 6 and HPV 11, and the malignant isolates, HPV 16 ... Significant sequence variation was found between the E6 to E7 regions of different integrated forms of HPV 18. On re- ...
more infohttps://infoscience.epfl.ch/record/151361

Human Papillomavirus (HPV) 16/18 E6 Oncoprotein Expression in Infections with Single and Multiple Genotypes | Cancer Prevention...Human Papillomavirus (HPV) 16/18 E6 Oncoprotein Expression in Infections with Single and Multiple Genotypes | Cancer Prevention...

Human Papillomavirus (HPV) 16/18 E6 Oncoprotein Expression in Infections with Single and Multiple Genotypes. Zeni Wu, Ting-Yuan ... Human Papillomavirus (HPV) 16/18 E6 Oncoprotein Expression in Infections with Single and Multiple Genotypes ... Human Papillomavirus (HPV) 16/18 E6 Oncoprotein Expression in Infections with Single and Multiple Genotypes ... Human Papillomavirus (HPV) 16/18 E6 Oncoprotein Expression in Infections with Single and Multiple Genotypes ...
more infohttp://cancerpreventionresearch.aacrjournals.org/content/12/2/95

Automated RNA In Situ Hybridization for 18 High Risk Human Papilloma Viruses in Squamous Cell Carcinoma of the Head and Neck: ...Automated RNA In Situ Hybridization for 18 High Risk Human Papilloma Viruses in Squamous Cell Carcinoma of the Head and Neck: ...

Detection of human papilloma virus (HPV)-related head and neck squamous cell carcinoma (HNSCC) is important, as HPV-associated ... Automated RNA In Situ Hybridization for 18 High Risk Human Papilloma Viruses in Squamous Cell Carcinoma of the Head and Neck: ... A direct clinical comparison between p16 IHC and an automated RNA ISH using 18 probes has not been established. Samples from 27 ... This easy to interpret automated staining method for 18 high-risk HPV genotypes is a feasible replacement for the indirect p16 ...
more infohttps://insights.ovid.com/pubmed?PMID=28777152

Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. |...Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. |...

Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters.. ... Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. ... Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. ... Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. ...
more infohttps://jvi.asm.org/content/64/6/2849/figures-only

Safety and Immunogenicity of TA-HPV, a Recombinant Vaccinia Virus Expressing Modified Human Papillomavirus (HPV)-16 and HPV-18...Safety and Immunogenicity of TA-HPV, a Recombinant Vaccinia Virus Expressing Modified Human Papillomavirus (HPV)-16 and HPV-18...

Shepherd P., Luxton J. T-cell responses to human papillomavirus in cervical dysplasia. Papillomavirus Report, 10: 53-59, 1999. ... IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. . Human Papillomaviruses, Vol. 64: IARC Lyon, France 1995. ... 3 The abbreviations used are: HPV, human papillomavirus; HLA, human leukocyte antigen; CIN, cervical intraepithelial neoplasia ... Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type-16 cervical lesions against a human ...
more infohttp://clincancerres.aacrjournals.org/content/8/12/3676

Synthetic peptides of human papillomavirus type 18 E6 harboring HLA-A2.1 motif can induce peptide-specific cytotoxic T-cells...Synthetic peptides of human papillomavirus type 18 E6 harboring HLA-A2.1 motif can induce peptide-specific cytotoxic T-cells...

In the binding assay of the synthetic peptides, 8 out of 18 synthetic peptides enhanced the expression of HLA-A2.1 molecules on ... HPV 18) E6 protein that might be useful for developing peptide-based vaccine against HPV 18 infection, 18 peptides which ... possibly contain CTL epitopes were selected on the basis of previously described human leukocyte antigen (HLA)-A2.1-binding ... Human T-Cell Responses to HLA-A-restricted High Binding Affinity Peptides of Human Papillomavirus Type 18 Proteins E 6 and E 71 ...
more infohttps://www.semanticscholar.org/paper/Synthetic-peptides-of-human-papillomavirus-type-18-Yoon-Chung/e3296f4047acea72ce6f89b4e23565941ea8a770